Prospective Realworld Cohort Study to Validate Effectiveness of an Artificial Intelligence defined Lung Nodule Malignancy Score in Patients with Pulmonary Nodule Multicentric, multinational, prospective, observational study.
35 Years - n/a
Endpoint Classification: -
Intervention Model: Single Group Assignment
Primary Purpose: Screening
Verified 01 Aug 2023 by AstraZeneca
No locations available
|Other: Computed tomography Cohort|
In case of any nodule detection by qXR, it will be classified either as low-risk LNMS(lung nodule malignancy score ) or high-risk LNMS confirmed by radiologist. The patient will be requested to get a CT scan after enrolment in the study.